Effect of 41°C and 43°C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin

Oncology Reports

Volumn 18, Issue 1, 2007, Pages 219-226

  Bergs, Judith W J ^a   Haveman, Jaap ^a   Ten Cate, Rosemarie ^a   Medema, Jan Paul ^a   Franken, Nicolaas A P ^a   Van Bree, Chris ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cisplatin; Hyperthermia; Radiosensitization

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ARTICLE; CELL CULTURE; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GAMMA RADIATION; HUMAN; HYPERTHERMIC THERAPY; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; RADIATION EXPOSURE; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG RESISTANCE, NEOPLASM; FEMALE; GAMMA RAYS; HUMANS; HYPERTHERMIA, INDUCED; LUNG NEOPLASMS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 34548047252     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.1.219     Document Type: Article

References (55)

1. Kampinga HH and Dikomey E: Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol 77: 399-408, 2001. (Pubitemid 32281123)
2. Roti Roti JL: Introduction: radiosensitization by hyperthermia. Int J Hyperthermia 20: 109-114, 2004.
3. Hildebrandt B, Wust P, Ahlers O, et al: The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43: 33-56, 2002. (Pubitemid 34722786)
4. Woudstra EC, Konings AW, Jeggo PA and Kampinga HH: Role of DNA-PK subunits in radiosensitization by hyperthermia. Radiat Res 152: 214-218, 1999. (Pubitemid 29374605)
5. Dynlacht JR, Bittner ME, Bethel JA and Beck BD: The non-homologous end-joining pathway is not involved in the radiosensitization of mammalian cells by heat shock. J Cell Physiol 196: 557-564, 2003. (Pubitemid 36927750)
6. Warters RL and Axtell J: Repair of DNA strand breaks at hyperthermic temperatures in Chinese hamster ovary cells. Int J Radiat Biol 61: 43-48, 1992.
7. Dewey WC, Sapareto SA and Betten DA: Hyperthermic radiosensitization of synchronous Chinese hamster cells: relationship between lethality and chromosomal aberrations. Radiat Res 76: 48-59, 1978.
8. Raaphorst GP, Yang DP and Niedbala G: Is DNA polymerase beta important in thermal radiosensitization? Int J Hyperthermia 20: 140-143, 2004. (Pubitemid 38425511)
9. Kampinga HH, Hiemstra YS, Konings AW and Dikomey E: Correlation between slowly repairable double-strand breaks and thermal radiosensitization in the human HeLa S3 cell line. Int J Radiat Biol 72: 293-301, 1997. (Pubitemid 27390824)
10. Ben Hur E, Elkind MM and Bronk BV: Thermally enhanced radioresponse of cultured Chinese hamster cells: inhibition of repair of sublethal damage and enhancement of lethal damage. Radiat Res 58: 38-51, 1974.
11. Kampinga HH, Dynlacht JR and Dikomey E: Mechanism of radiosensitization by hyperthermia (> or = 43 degrees C) as derived from studies with DNA repair defective mutant cell lines. Int J Hyperthermia 20: 131-139, 2004. (Pubitemid 38425510)
12. Kampinga HH, Kanon B, Konings AW, Stackhouse MA and Bedford JS: Thermal radiosensitization in heat- and radiation-sensitive mutants of CHO cells. Int J Radiat Biol 64: 225-230, 1993. (Pubitemid 23266764)
13. Laszlo A, Davidson T, Harvey A, et al: Alterations in heat-induced radiosensitization accompanied by nuclear structure alterations in Chinese hamster cells. Int J Hyperthermia 22: 43-60, 2006. (Pubitemid 43158216)
14. Kampinga HH: Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field. Int J Hyperthermia 22: 191-196, 2006.
15. Haveman J, Bergs JW, Franken NA, van Bree C and Stalpers LJ: Effect of hyperthermia on uptake and cytotoxicity of cisplatin in cultured murine mammary carcinoma cells. Oncol Rep 14: 561-567, 2005.
16. van Bree C, Rietbroek RC, Schopman EM, Kipp JB and Bakker PJ: Local hyperthermia enhances the effect of cis-diamminedichloroplatinum(II) on nonirradiated and preirradiated rat solid tumors. Int J Radiat Oncol Biol Phys 36: 135-140, 1996. (Pubitemid 126745242)
17. Wondergem J, Bulger RE, Strebel FR, et al: Effect of cis- diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Res 48: 440-446, 1988. (Pubitemid 18045784)
18. Los G, van Vugt MJ and Pinedo HM: Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 69: 235-241, 1994. (Pubitemid 24046543)
19. Urano M, Kahn J, Majima H and Gerweck LE: The cytotoxic effect of cis-diamminedichloroplatinum(II) on cultured Chinese hamster ovary cells at elevated temperatures: Arrhenius plot analysis. Int J Hyperthermia 6: 581-590, 1990. (Pubitemid 20238383)
20. Herman TS, Teicher BA, Cathcart KN, Kaufmann ME, Lee JB and Lee MH: Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline. Cancer Res 48: 5101-5105, 1988.
21. Wallner KE, DeGregorio MW and Li GC: Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res 46: 6242-6245, 1986. (Pubitemid 17221763)
22. Ohtsubo T, Saito H, Tanaka N, Tsuzuki H, Saito T and Kano E: In vitro effect of hyperthermia on chemoenhancement and uptake of cisplatin in human pharyngeal carcinoma KB cells. Chemotherapy 43: 43-50, 1997. (Pubitemid 27007927)
23. Wilkins DE, Heller DP and Raaphorst GP: Inhibition of potentially lethal damage recovery by cisplatin in a brain tumor cell line. Anticancer Res 13: 2137-2142, 1993. (Pubitemid 24036340)
24. Bergs JW, Franken NA, ten Cate R, van Bree C and Haveman J: Effects of cisplatin and gamma-irradiation on cell survival, the induction of chromosomal aberrations and apoptosis in SW-1573 cells. Mutat Res 594: 148-154, 2006. (Pubitemid 43170994)
25. Raaphorst GP, Maio J, Ng CE and Stewart DJ: Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin. Oncol Rep 5: 971-977, 1998.
26. Raaphorst GP, Yang H, Wilkins DE and Ng CE: Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and -resistant glioma cell lines. Int J Hyperthermia 12: 801-812, 1996. (Pubitemid 26402366)
27. Salcman M and Ebert PS: In vitro response of human glioblastoma and canine glioma cells to hyperthermia, radiation, and chemotherapy. Neurosurgery 29: 526-531, 1991.
28. Westermann AM, Jones EL, Schem BC, et al: First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 104: 763-770, 2005. (Pubitemid 41113675)
29. Dewhirst MW, Vujaskovic Z, Jones E and Thrall D: Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 21: 779-790, 2005. (Pubitemid 41818597)
30. van der Zee J, Gonzalez GD, van Rhoon GC, van Dijk JD, van Putten WL and Hart AA: Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355: 1119-1125, 2000.
31. Franken NAP, Rodermond HM, Stap J, Haveman J and van Bree C: The clonogenic assay of cells in vitro. Nat Protocols (In press).
32. Nagai N, Kinoshita M, Ogata H, et al: Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients. Cancer Chemother Pharmacol 39: 131-137, 1996. (Pubitemid 26400671)
33. Raaphorst GP, Heller DP, Bussey A and Ng CE: Thermal radiosensitization by 41 degrees C hyperthermia during low dose-rate irradiation in human normal and tumour cell lines. Int J Hyperthermia 10: 263-270, 1994.
34. El Awady RA, Dikomey E and Dahm-Daphi J: Heat effects on DNA repair after ionising radiation: hyperthermia commonly increases the number of non-repaired double-strand breaks and structural rearrangements. Nucleic Acids Res 29: 1960-1966, 2001. (Pubitemid 32433281)
35. Xu M, Wright WD, Higashikubo R, Wang LL and Roti Roti JL: Thermal radiosensitization of human tumour cell lines with different sensitivities to 41.1 degrees C. Int J Hyperthermia 15: 279-290, 1999. (Pubitemid 29349003)
36. Ryu S, Brown SL, Kim SH, Khil MS and Kim JH: Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys 34: 133-138, 1996. (Pubitemid 26019962)
37. Myerson RJ, Roti Roti JL, Moros EG, Straube WL and Xu M: Modelling heat-induced radiosensitization: clinical implications. Int J Hyperthermia 20: 201-212, 2004. (Pubitemid 38425517)
38. Oleson JR: Eugene Robertson special lecture. Hyperthermia from the clinic to the laboratory: a hypothesis. Int J Hyperthermia 11: 315-322, 1995.
39. Song CW, Shakil A, Osborn JL and Iwata K: Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 12: 367-373, 1996. (Pubitemid 26158699)
40. Begg AC, van der Kolk PJ, Dewit L and Bartelink H: Radiosensitization by cisplatin of RIF1 tumour cells in vitro.Int J Radiat Biol Relat Stud Phys Chem Med 50: 871-884, 1986. (Pubitemid 17179659)
41. Diggle CP, Bentley J, Knowles MA and Kiltie AE: Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts. Nucleic Acids Res 33: 2531-2539, 2005. (Pubitemid 41511272)
42. Wilson GD, Bentzen SM and Harari PM: Biologic basis for combining drugs with radiation. Semin Radiat Oncol 16: 2-9, 2006. (Pubitemid 41832311)
43. Boeckman HJ, Trego KS and Turchi JJ: Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of non-homologous end joining. Mol Cancer Res 3: 277-285, 2005. (Pubitemid 40656815)
44. Gorodetsky R, Levy-Agababa F, Mou X and Vexler AM: Combination of cisplatin and radiation in cell culture: effect of duration of exposure to drug and timing of irradiation. Int J Cancer 75: 635-642, 1998. (Pubitemid 28094113)
45. Myint WK, Ng C and Raaphorst GP: Examining the non-homologous repair process following cisplatin and radiation treatments. Int J Radiat Biol 78: 417-424, 2002. (Pubitemid 34496892)
46. Brabec V and Kasparkova J: Molecular aspects of resistance to antitumor platinum drugs. Drug Resist Updat 5: 147-161, 2002. (Pubitemid 35033806)
47. Mansouri A, Henle KJ, Benson AM, Moss AJ and Nagle WA: Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia. Cancer Res 49: 2674-2678, 1989. (Pubitemid 19143397)
48. Hettinga JVE: Reduction of cisplatin resistance by hyperthermia. Thesis at the University of Groningen, 1996.
49. Meyn RE, Corry PM, Fletcher SE and Demetriades M: Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res 40: 1136-1139, 1980. (Pubitemid 10135821)
50. Hettinga JV, Lemstra W, Meijer C, et al: Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells. Br J Cancer 75: 1735-1743, 1997. (Pubitemid 27230697)
51. Krishnaswamy G and Dewey WC: Cell killing and chromosomal aberrations induced in Chinese hamster ovary cells by treating with cisplatin at 41.5 degrees C during the G1 or late S phase. Cancer Res 53: 1239-1243, 1993. (Pubitemid 23097095)
52. van de Vaart PJ, van der Vange N, Zoetmulder FA, et al:Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer 34: 148-154, 1998. (Pubitemid 28123393)
53. Raaphorst GP, Doja S, Davis L, Stewart D and Ng CE: A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacol 37: 574-580, 1996. (Pubitemid 26080155)
54. Raaphorst GP, Miao J, Stewart D and Ng CE: Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells. Cancer Chemother Pharmacol 41: 491-496, 1998. (Pubitemid 28140714)
55. Raaphorst GP, Miao J and Ng CE: Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells. Anticancer Res 17: 3469-3472, 1997. (Pubitemid 27522311)